Скачать или смотреть Revolutionary Glaucoma Treatment with Intraocular Lens: Highlights from AGS 2025 - SpyGlass

Dr. Nathan Radcliffe reports from the 2025 American Glaucoma Society meeting in Washington, DC, where Dr. Jason Bacharach presented groundbreaking technology from SpyGlass. The new glaucoma treatment involves an intraocular lens with drug pads that elute bimatoprost over 36 months. The procedure mirrors traditional cataract surgery, making it easily adoptable. Data from the first human studies on 23 patients over 18 months showed a 43.7% intraocular pressure reduction, 20/30 vision or better in all patients, and 100% of patients off drops. This innovation promises significant advancements for glaucoma and cataract patients.

00:00 Introduction and Welcome
00:14 Overview of SpyGlass Technology
00:40 Procedure and Accessibility
01:01 First Human Studies Data
01:15 Promising Results and Vision Outcomes
01:55 Conclusion and Future Outlook